Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Clinical trial NCT00324987 · TERMINATED
Trial details
- NCT number
- NCT00324987
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2015-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.